F

Amicus Therapeutics

D
FOLD
USD
-0.27
(-2.4043%)
Market Closed
159,679.00
Volume
-0.168
EPS
-
Div Yield
-28.153846
P/E
3,250,636,603.76
Market Cap
Today
-2.4043%
1 Week
-4.028%
1 Month
7.451%
6 Months
5.182%
12 Months
-6.245%
Year To Date
-22.817%
All Time
0%

Title:
Amicus Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
Do you need help or have a question?